Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

235.00 4.15 −1.74%
Market cap
$26.4B
P/E
24.6×
Fwd P/E
20.8×
Dividend yield
1.44%
F-score
8/9
Altman Z
3.15
Beneish M
−2.65
Dividend safety
85/100

Quest Diagnostics Incorporated (DGX) Net income

Alert me on Net income

Quest Diagnostics Incorporated's net income for fiscal 2025 was $1.0B, up 13.6% from $921.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.1B. Over the past ten years it has ranged from $696.0M (fiscal 2016) to $2.1B (fiscal 2021); the current reading is higher than 82% of that period. Quest Diagnostics Incorporated ranks 6th of 52 Diagnostics & Research companies by net income.

Net income, annual

Embed this chart

Annual newest first

Period Net income Change
FY2025 $1.0B 13.57%
FY2024 $921.0M 1.43%
FY2023 $908.0M (10.54%)
FY2022 $1.0B (51.20%)
FY2021 $2.1B 38.76%
FY2020 $1.5B 65.45%
FY2019 $906.0M 14.97%
FY2018 $788.0M (4.37%)
FY2017 $824.0M 18.39%
FY2016 $696.0M (7.57%)

Quarterly newest first

Period Net income Change
Jun 2026 $334.0M 26.52%
Mar 2026 $264.0M 3.13%
Dec 2025 $256.0M (1.16%)
Sep 2025 $259.0M (12.50%)
42 more quarters

Against its own ten years

Low $696.0M High $2.1B
Ten-year median $908.0M
Current reading's percentile 82

Net income against peers

What Net income is

Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.

Reported line item

The full definition of Net income →

More on DGX